Respiratory Distress in the Newborn
Am Fam Physician. 2007 Oct 1;76(7):987-994.
The most common etiology of neonatal respiratory distress is transient tachypnea of the newborn; this is triggered by excessive lung fluid, and symptoms usually resolve spontaneously. Respiratory distress syndrome can occur in premature infants as a result of surfactant deficiency and underdeveloped lung anatomy. Intervention with oxygenation, ventilation, and surfactant replacement is often necessary. Prenatal administration of corticosteroids between 24 and 34 weeks' gestation reduces the risk of respiratory distress syndrome of the newborn when the risk of preterm delivery is high. Meconium aspiration syndrome is thought to occur in utero as a result of fetal distress by hypoxia. The incidence is not reduced by use of amnio-infusion before delivery nor by suctioning of the infant during delivery. Treatment options are resuscitation, oxygenation, surfactant replacement, and ventilation. Other etiologies of respiratory distress include pneumonia, sepsis, pneumothorax, persistent pulmonary hypertension, and congenital malformations; treatment is disease specific. Initial evaluation for persistent or severe respiratory distress may include complete blood count with differential, chest radiography, and pulse oximetry.
The clinical presentation of respiratory distress in the newborn includes apnea, cyanosis, grunting, inspiratory stridor, nasal flaring, poor feeding, and tachypnea (more than 60 breaths per minute). There may also be retractions in the intercostal, subcostal, or supracostal spaces. Respiratory distress occurs in approximately 7 percent of infants,1 and preparation is crucial for physicians providing neonatal care. Most cases are caused by transient tachypnea of the newborn, respiratory distress syndrome, or meconium aspiration syndrome, but various other causes are possible (Table 1).
SORT: KEY RECOMMENDATIONS FOR PRACTICE
SORT: KEY RECOMMENDATIONS FOR PRACTICE
|Clinical recommendation||Evidence rating||References|
Prenatal administration of corticosteroids between 24 and 34 weeks' gestation reduces the risk of respiratory distress syndrome of the newborn when the risk of preterm delivery is high.
Oronasopharyngeal suctioning before shoulder delivery does not prevent meconium aspiration syndrome.
Use of selective serotonin reuptake inhibitors in late pregnancy may cause persistent pulmonary hypertension of the newborn.
A = consistent, good-quality patient-oriented evidence; B = inconsistent or limited-quality patient-oriented evidence; C = consensus, disease-oriented evidence, usual practice, expert opinion, or case series. For information about the SORT evidence rating system, see page 922 or http://www.aafp.org/afpsort.xml.
Table 1. Differential Diagnosis of Respiratory Distress in the Newborn
Differential Diagnosis of Respiratory Distress in the Newborn
Most common causes*
Transient tachypnea of the newborn
Respiratory distress syndrome (hyaline membrane disease)
Meconium aspiration syndrome
Less common but significant causes
Infection (e.g., pneumonia, sepsis)
Nonpulmonary causes (e.g., anemia, congenital heart disease, congenital malformation, medications, neurologic or metabolic abnormalities, polycythemia, upper airway obstruction)
Persistent pulmonary hypertension of the newborn
*—Listed in order of incidence.
Transient Tachypnea of the Newborn
Transient tachypnea of the newborn is the most common cause of neonatal respiratory distress, constituting more than 40 percent of cases.1 A benign condition, it occurs when residual pulmonary fluid remains in fetal lung tissue after delivery. Prostaglandins released after delivery dilate lymphatic vessels to remove lung fluid as pulmonary circulation increases with the first breath. When fluid persists despite these mechanisms, transient tachypnea of the newborn can result. Risk factors include maternal asthma,2 male sex, macrosomia, maternal diabetes,3 and cesarean delivery.4
The clinical presentation includes tachypnea immediately after birth or within two hours, with other predictable signs of respiratory distress. Symptoms can last from a few hours to two days. Chest radiography shows diffuse parenchymal infiltrates, a “wet silhouette” around the heart, or intralobar fluid accumulation5 (Figure 1).
Respiratory Distress Syndrome
Respiratory distress syndrome of the newborn, also called hyaline membrane disease, is the most common cause of respiratory distress in premature infants, correlating with structural and functional lung immaturity. It occurs in 24,000 infants born in the United States annually.6 It is most common in infants born at fewer than 28 weeks' gestation and affects one third of infants born at 28 to 34 weeks' gestation, but occurs in less than 5 percent of those born after 34 weeks' gestation.6 The condition is more common in boys,7 and the incidence is approximately six times higher in infants whose mothers have diabetes, because of delayed pulmonary maturity despite macrosomia.8
The pathophysiology is complex. Immature type II alveolar cells produce less surfactant, causing an increase in alveolar surface tension and a decrease in compliance. The resultant atelectasis causes pulmonary vascular constriction, hypoperfusion, and lung tissue ischemia. Hyaline membranes form through the combination of sloughed epithelium, protein, and edema. Persistent respiratory distress syndrome leads to bronchopulmonary dysplasia, characterized by typical chest radiography findings and chronic oxygen dependence. The syndrome is associated with recurrent wheezing in children and a higher risk of hospital admission for asthma.9
The diagnosis of respiratory distress syndrome should be suspected when grunting, retractions, or other typical distress symptoms occur in a premature infant immediately after birth. Hypoxia and cyanosis often occur. Chest radiography shows homogenous opaque infiltrates and air bronchograms, indicating contrast in airless lung tissue seen against air-filled bronchi5(Figure 2); decreased lung volumes also can be detected.
Meconium Aspiration Syndrome
Meconium-stained amniotic fluid occurs in approximately 15 percent of deliveries, causing meconium aspiration syndrome in the infant in 10 to 15 percent of those cases, typically in term and post-term infants.10 Meconium is composed of desquamated cells, secretions, lanugo, water, bile pigments, pancreatic enzymes, and amniotic fluid. Although sterile, meconium is locally irritative, obstructive, and a medium for bacterial culture. Meconium passage may represent hypoxia or fetal distress in utero. Similar symptoms can occur after aspiration of blood or nonstained amniotic fluid.
Meconium aspiration syndrome causes significant respiratory distress immediately after delivery. Hypoxia occurs because aspiration takes place in utero. Chest radiography shows patchy atelectasis or consolidation5(Figure 3).
Bacterial infection is another possible cause of neonatal respiratory distress. Common pathogens include group B streptococci (GBS), Staphylococcus aureus, Streptococcus pneumoniae, and gram-negative enteric rods. Pneumonia and sepsis have various manifestations, including the typical signs of distress as well as temperature instability. Unlike transient tachypnea, respiratory distress syndrome, and meconium aspiration syndrome, bacterial infection takes time to develop, with respiratory consequences occurring hours to days after birth.
Risk factors for pneumonia include prolonged rupture of membranes, prematurity, and maternal fever. Prevention of GBS infection through universal screening and antepartum treatment reduces rates of early-onset disease, including pneumonia and sepsis, by 80 percent.11 Current U.S. protocol mandates screening for GBS in all pregnant patients late in pregnancy and treating those who have positive results with intrapartum antibiotics at least four hours before delivery.12
Chest radiography helps in the diagnosis, with bilateral infiltrates suggesting in utero infection. Pleural effusions are present in two thirds of cases.13 Serial blood cultures may be obtained to later identify an infecting organism.
Less Common Causes
Pneumothorax, defined as air in the pleural space, can be a cause of neonatal respiratory distress when pressure within the pulmonary space exceeds extrapleural pressure. It can occur spontaneously or as a result of infection, meconium aspiration, lung deformity, or ventilation barotrauma. The incidence of spontaneous pneumothorax is 1 to 2 percent in term births,14 but it increases to about 6 percent in premature births.15
Persistent pulmonary hypertension of the newborn occurs when pulmonary vascular resistance fails to decrease soon after birth as with normal transition. The etiology may be idiopathic or secondary to meconium aspiration syndrome, pneumonia or sepsis, respiratory distress syndrome, or transient tachypnea of the newborn. Maternal use of selective serotonin reup-take inhibitors in the third trimester also has been implicated.16
Certain congenital malformations can lead to respiratory distress; these include pulmonary hypoplasia, congenital emphysema, esophageal atresia, and diaphragmatic hernia. Upper airway obstructions from choanal atresia or vascular rings may cause similar results. Obstructive lesions include choanal atresia, macroglossia, Pierre Robin syndrome, lymphangioma, teratoma, mediastinal masses, cysts, subglottic stenosis, and laryngotracheomalacia. Congenital heart disease also may be implicated. Cyanotic heart disease includes transposition of the great arteries and tetralogy of Fallot. Noncyanotic heart lesions may cause a pulmonary overflow state leading to congestive heart failure. These lesions include large septal defects, patent ductus arteriosus, and coarctation of the aorta. Malformations can sometimes be found on antepartum imaging.
Neurologic disorders such as hydrocephalus and intracranial hemorrhage can cause respiratory distress. Central respiratory depression can occur after maternal exposure to medications, including labor analgesia and illicit drugs.
Metabolic and hematologic derangements (e.g., hypoglycemia, hypocalcemia, polycythemia, anemia) can also cause respiratory symptoms. Inborn errors of metabolism should also be considered.
Finally, a small but significant number of infants do not fit previously described patterns. Delayed transition is diagnosed retrospectively when symptoms resolve within the first few hours of life instead of progressing as respiratory distress syndrome, transient tachypnea of the newborn, or meconium aspiration syndrome. The etiology is most likely a combination of retained fluid and incompletely expanded alveoli. Treatment is supportive until the distress resolves in a few hours as the transition completes.
Treatment for neonatal respiratory distress can be both generalized and disease-specific. Physicians should be aware of current neonatal resuscitation protocols. Oxygenation can be enhanced with blow-by oxygen, nasal cannula, or mechanical ventilation in severe cases. Surfactant administration may be required. Antibiotics are often administered if bacterial infection is suspected clinically or because of leukocytosis, neutropenia, or hypoxemia. Ampicillin and gentamicin are often used together based on their effectiveness and synergy.12 Extracorporeal membrane oxygenation, similar to an artificial external lung, is used as a last resort in critical circumstances. Oral feedings are often withheld if the respiratory rate exceeds 80 breaths per minute.
If pneumothorax occurs, needle decompression or chest tube drainage may be required. Small pneumothoraces can be treated in term infants without invasive management through nitrogen washout. Administration of 100% oxygen can accelerate the resolution of the pneumothorax as readily absorbed oxygen replaces nitrogen in the extrapulmonary space. This technique can reduce pneumothorax duration from two days to eight hours.17
Because evidence in the specific treatment of neonatal respiratory distress continues to evolve, family physicians should work conjointly with neonatal intensivists. If services required for the neonate are unavailable at the family physician's facility, care should be transferred to a higher acuity hospital.
TRANSIENT TACHYPNEA OF THE NEWBORN
Treatment for transient tachypnea of the newborn is supportive because the condition is usually self-limited. Oral furosemide (Lasix) has not been shown to significantly improve status and should not be given.18 Data suggest that prenatal administration of corticosteroids 48 hours before elective cesarean delivery at 37 to 39 weeks' gestation reduces the incidence of transient tachypnea of the newborn; however, this has not become common practice.19
RESPIRATORY DISTRESS SYNDROME
Treatment for respiratory distress syndrome often requires some of the general interventions mentioned. In addition, prenatal administration of corticosteroids between 24 and 34 weeks' gestation reduces the risk of respiratory distress syndrome when the risk of preterm delivery is high, with an odds ratio of 0.53.20 Postnatal corticosteroid administration for respiratory distress syndrome may decrease mortality risk, but it may increase the risk of cerebral palsy.21 Inhaled nitric oxide may alleviate concomitant persistent pulmonary hypertension of the newborn, but its use in preterm infants is experimental.22
MECONIUM ASPIRATION SYNDROME
General treatment practices are often used for meconium aspiration syndrome. Standard prevention and treatment for meconium aspiration syndrome previously included suctioning the mouth and nares upon head delivery before body delivery. However, recent evidence suggests that aspiration occurs in utero, not at delivery; therefore, infant delivery should not be impeded for suctioning.23 After full delivery, the infant should be handed to a neonatal team for evaluation and treatment. Although infants previously have been given intubation and airway suctioning, current evidence favors expectant management unless certain criteria (i.e., spontaneous respiration, heart rate greater than 100 beats per minute, and reasonable tone) are absent (Figure 4).24
Meta-analyses have suggested that amnioinfusion reduces aspiration for thick meconium.25,26 A recent well-designed, randomized, multicenter trial with 1,998 women found that amnioinfusion for meconium (even thick meconium) does not decrease the incidence of meconium aspiration syndrome or perinatal death.27 There is insufficient evidence to recommend steroid administration.28
A detailed history is critical to proper evaluation. The differential diagnosis changes with gestational age: respiratory distress syndrome typically affects preterm infants, whereas meconium aspiration syndrome affects term or post-term neonates. Antepartum infection status is important, especially regarding GBS infection status and prophylaxis. Information about the duration of rupture, color of amniotic fluid, maternal temperature, maternal tachycardia, and fetal heart tracing status is vital to detect meconium aspiration and chorioamnionitis. Family history assists in identifying inheritable congenital defects. The onset and duration of respiratory symptoms also provide clues. Transient tachypnea of the newborn begins early and improves with time. Conversely, sepsis and pneumonia may have no early signs but may develop hours to days later. Respiratory distress syndrome begins early in premature infants without signs of spontaneous improvement.
Physical examination also is helpful. In the general assessment, physicians should look for apnea, tachypnea, or cyanosis. Cardiac auscultation detects murmurs suggestive of congenital heart anomalies. Lung auscultation may show asymmetrical chest movement in pneumothorax or crackles in pneumonia, or be completely clear in transient tachypnea or persistent pulmonary hypertension of the newborn.
The severity of distress should be estimated with an initial assessment. Mild distress may warrant observation and pulse oximetry. Severe distress, especially with a complicated birth history, requires immediate resuscitation, chest radiography, and laboratory tests. Newborns commonly demonstrate signs of respiratory compromise much earlier than cardiovascular collapse. The variation of neonatal distress makes application of a general algorithm difficult, although a “rule of two hours” for continuous reassessment has been suggested (Figure 5).29 During this time, chest radiography and blood tests can be performed (Table 2), and possible consultation or patient transfer can be implemented. This reassessment allows physicians to reevaluate symptom severity as well as to update and educate the parents.
Table 2 Laboratory Evaluation for Respiratory Distress in the Newborn
Laboratory Evaluation for Respiratory Distress in the Newborn
May indicate bacteremia Not helpful initially because results may take 48 hours
Used to assess degree of hypoxemia if arterial sampling, or acid/base status if capillary sampling (capillary sample usually used unless high oxygen requirement)
Hypoglycemia can cause or aggravate tachypnea
Used to differentiate various types of respiratory distress
Complete blood count with differential
Leukocytosis or bandemia indicates stress or infection
Neutropenia correlates with bacterial infection
Low hemoglobin level shows anemia
High hemoglobin level occurs in polycythemia
Low platelet level occurs in sepsis
If meningitis is suspected
Used to detect hypoxia and need for oxygen supplementation
Table 3 Distinguishing Features of TTN, RDS, and MAS
Distinguishing Features of TTN, RDS, and MAS
|Cause||Etiology||Timing of delivery||Risk factors||Clinicalfeatures||Chest radiography findings||Treatment||Prevention|
Persistent lung fluid
Supportive, oxygen if hypoxic
Prenatal corticosteroids before cesarean delivery if 37 to 39 weeks' estimated gestation (not accepted U.S. practice)19
Resuscitation, oxygen, ventilation, surfactant
Prenatal corticosteroids if risk of preterm delivery (24 to 34 weeks' estimated gestation)20 (accepted U.S. practice)
Lung irritation and obstruction
Term or post-term
Resuscitation, oxygen, ventilation, surfactant
1. Kumar A, Bhat BV. Epidemiology of respiratory distress of newborns. Indian J Pediatr. 1996;63:93–8.
2. Demissie K, Marcella SW, Breckenridge MB, Rhoads GG. Maternal asthma and transient tachypnea of the newborn. Pediatrics. 1998;1021 pt 184–90.
3. Persson B, Hanson U. Neonatal morbidities in gestational diabetes mellitus. Diabetes Care. 1998;21suppl 2B79–84.
4. Levine EM, Ghai V, Barton JJ, Strom CM. Mode of delivery and risk of respiratory diseases in newborns. Obstet Gynecol. 2001;97:439–42.
5. Kurl S, Heinonen KM, Kiekara O. The first chest radiograph in neonates exhibiting respiratory distress at birth. Clin Pediatr (Phila). 1997:285–9.
6. Respiratory distress syndrome of the newborn fact sheet. American Lung Association, 2006. Accessed May 7, 2007, at: http://www.lungusa.org/site/pp.asp?c=dvLUK9O0E&b=35693.
7. Ingemarrson I. Gender aspects of preterm birth. BJOG. 2003;110suppl 2034–8.
8. Cowett RM. The infant of the diabetic mother. Neoreviews. 2002;3:e173–89.
9. Koivisto M, Marttila R, Saarela T, Pokela ML, Valkama AM, Hallman M. Wheezing illness and re-hospitalization in the first two years of life after neonatal respiratory distress syndrome. J Pediatr. 2005;147:486–92.
10. Cleary GM, Wiswell TE. Meconium-stained amniotic fluid and the meconium aspiration syndrome. An update. Pediatr Clin North Am. 1998;45:511–29.
11. Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep. 2002;51RR-111–22.
12. Edwards MS. Antibacterial therapy in pregnancy and neonates. Clin Perinatol. 1997;24:251–66.
13. Cleveland RH. A radiologic update on medical diseases of the newborn chest. Pediatr Radiol. 1995;25:631–7.
14. Davis C, Stevens G. Value of routine radiographic examination of the newborn, based on a study of 702 consecutive babies. Am J Obstet Gynecol. 1930;20:73.
15. Horbar JD, Badger GJ, Carpenter JH, Fanaroff AA, Kilpatrick S, LaCorte M, et al., Members of the Vermont Oxford Network. Trends in mortality and morbidity for very low birth weight infants, 1991–1999. Pediatrics. 2002;1101 pt 1143–51.
16. Chambers CD, Hernandez-Diaz S, Van Marter LJ, Werler MM, Louik C, Jones KL, et al. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med. 2006;354:579–87.
17. Al Tawil K, Abu-Ekteish FM, Tamimi O, Al Hathal MM, Al Hathlol K, Abu Laimun B. Symptomatic spontaneous pneumothorax in term newborn infants. Pediatr Pulmonol. 2004;37:443–6.
18. Lewis V, Whitelaw A. Furosemide for transient tachypnea of the newborn. Cochrane Database Syst Rev. 2002;(1):CD003064.
19. Stutchfield P, Whitaker R, Russel I, for the Antenatal Steroids for Term Elective Cesarean Section (ASTECS) Research Team. Antenatal betamethasone and incidence of neonatal respiratory distress after elective cesarean section: pragmatic randomized trial. BMJ. 2005;331:662–4.
20. Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2006;(3):CD004454.
21. Doyle LW, Halliday HL, Ehrenkranz RA, Davis PG, Sinclair JC. Impact of postnatal systemic corticosteroids on mortality and cerebral palsy in preterm infants: effect modification by risk for chronic lung disease. Pediatrics. 2005;115:655–61.
22. Barrington KJ, Finer NN. Inhaled nitric oxide for respiratory failure in preterm infants. Cochrane Database Syst Rev. 2006;(1):CD000509.
23. Vain NE, Szyld EG, Prudent LM, Wiswell TE, Aguilar AM, Vivas NI. Oropharyngeal and nasopharyngeal suctioning of meconium-stained neonates before delivery of their shoulders: multicentre, randomised controlled trial. Lancet. 2004;364:597–602.
24. Wiswell TE, Gannon CM, Jacob J, Goldsmith L, Szyld E, Weiss K, et al. Delivery room management of the apparently vigorous meconium-stained neonate: results of the multicenter, international collaborative trial. Pediatrics. 2000;105:1–7.
25. Hofmeyr GJ, Gulmezoglu AM, Buchmann E, Howarth GR, Shaw A, Nikodem VC, et al. The Collaborative Randomised Amnioinfusion for Meconium Project (CRAMP): 1. South Africa. Br J Obstet Gynaecol. 1998;105:304–8.
26. Hofmeyr GJ. Amnioinfusion for meconium-stained liquor in labour. Cochrane Database Syst Rev. 2000;(1):CD000014.
27. Fraser WD, Hofmeyr J, Lede R, Faron G, Alexander S, Goffinet F, et al., for the Amnioinfusion Trial Group. Amnioinfusion for the prevention of the meconium aspiration syndrome. N Engl J Med. 2005;353:909–17.
28. Ward M, Sinn J. Steroid therapy for meconium aspiration syndrome in newborn infants. Cochrane Database Syst Rev. 2003;(4):CD003485.
29. Hein HH, Ely JW, Lofgren MA. Neonatal respiratory distress in the community hospital: when to transport, when to keep. J Fam Pract. 1998;46:284–9.
Copyright © 2007 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact firstname.lastname@example.org for copyright questions and/or permission requests.
Want to use this article elsewhere? Get Permissions